Impact on the prognosis with the creation of a dedicated stroke to mesenteric ischaemia

Acute mesenteric ischaemia (AMI) is an emergency with a poor prognosis. In France, a structure dedicated to AMI has been created in Paris in 2016 (SURVI), with promising results. A similar organization has been created in Marseille in 2021 (SOS AMI). Our aim was to compare the results of SOS AMI with those of a previous cohort of AMI patients managed without any dedicated structure.

The first 100 patients with AMI, managed by the SOS AMI, between November 2021 and December 2023 were prospectively included. They were compared with 100 AMI patients from a previous retrospective cohort (from January 2017 to December 2020), managed without any dedicated structure in the same center.

The first 100 AMI patients managed by SOS AMI have similar demographic characteristics to those previously managed without SOS. The vascular causes of AMI were also similar between groups: arterial occlusive (61 vs. 56%, p = 0.5), venous occlusive (17 vs. 13%, p = 0.5), or non occlusive (22 vs. 31%, p = 0.2). AMI patients managed by SOS AMI were more frequently transferred from another center (41 vs. 19%, p = 0.001), had a shorter median time between CT scan and intervention (4 [range, 1-129] vs. 5 [0-285] hours, p = 0.05), a higher revascularisation rate (61 vs. 28%, p = 0.02), and lower 30-day (32 vs. 58%, p < 0.001) and 90-day (45 vs. 62%, p = 0.02) mortality rates.

The creation of SOS AMI has significantly improved the management of AMI patients, by better organizing the role of the various specialties involved, particularly in terms of revascularisation and survival rates. These promising results support the further development and expansion of this dedicated structure.